Capricor Therapeutics, Inc. (CAPR)
28.86
-1.18
(-3.93%)
USD |
NASDAQ |
Dec 30, 14:14
Capricor Therapeutics EPS Diluted (Quarterly): -0.5375 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.133 |
| Inovio Pharmaceuticals, Inc. | -0.8721 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Arcturus Therapeutics Holdings, Inc. | -0.4946 |
| Myomo, Inc. | -0.0869 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -24.57M |
| Total Expenses (Quarterly) | 24.57M |
| Enterprise Value | 1.293B |
| Earnings Yield | -6.23% |
| Normalized Earnings Yield | -6.233 |